Strong cytokeratin 5/6, cytokeratin 14, and cytokeratin 17 expression |
Negative hormone receptor tumors, with low expression of HER2 |
May express epidermal growth factor receptors and c-kit receptors |
High histologic grade and worse prognosis than nonbasaloid triple-negative tumors |
BRCA1 mutation |